• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Vertex Pharmaceuticals

Vertex Pharmaceuticals

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. UPDATE: Bank of America rises on profits; Netflix falls after stock split

    UPDATE: Bank of America rises on profits; Netflix falls after stock split

  2. UPDATE: Netflix, Intel shares rally after earnings reports

    UPDATE: Netflix, Intel shares rally after earnings reports

  3. UPDATE: Netflix, Intel shares rally after earnings reports

    UPDATE: Netflix, Intel shares rally after earnings reports

  4. UPDATE: Tesla, Xoom shares jump; Western Union, Yelp drop

    UPDATE: Tesla, Xoom shares jump; Western Union, Yelp drop

  5. ADDING MULTIMEDIA FDA Approves ORKAMBI™ (lumacaftor/ivacaftor) - the First Medicine to Treat the Underlying Cause of Cystic Fibrosis for People Ages 12 and Older with Two Copies of the F508del ...

    ADDING MULTIMEDIA FDA Approves ORKAMBI™ (lumacaftor/ivacaftor) - the First Medicine to Treat the Underlying Cause of Cystic Fibrosis for People Ages 12 and Older with Two Copies of the F508del Mutation

  6. Cystic Fibrosis Foundation Celebrates FDA Approval of Orkambi as an Important Advance for the Cystic Fibrosis Community

    Cystic Fibrosis Foundation Celebrates FDA Approval of Orkambi as an Important Advance for the Cystic Fibrosis Community

  7. A Favorable Prognosis for This Pharma Stock

    Recent clinical success in cystic fibrosis positions Vertex as a dominant player in this attractive rare-disease market.

  8. Five Consensus Views that Could Prove Wrong in 2015

    Options on this firm's blockbuster cost a little but pay off big.

  9. Reinvent Your Practice: Alternatives to Traditional Succession Planning

    Following is a roundup of stocks that recently jumped to 5 stars in the last week. By way of background, we award a stock 5 stars when it trades at a suitably large discount--i.e., a margin of safety--to our fair value estimate. Thus, when a stock hits 5-star territory, we consider it an especially ...

  10. How Did Facebook End Up in the S&P 500?

    We dive into the process for adding companies and booting them from the iconic index.

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.